Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Women Health Diagnostics Market size was over USD 19.97 billion in 2024 and is poised to exceed USD 49.31 billion by 2037, witnessing over 7.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of women health diagnostics is evaluated at USD 21.19 billion.
The growth of the market can be attributed to the rising awareness levels about various health disorders across the globe, and increasing prevalence of lifestyle and chronic diseases among women. According to the Pan American Health Organization, in 2019, a total of 534,242 deaths occurred due to chronic respiratory diseases in the region of the Americas alone, out of which 266,725, i.e., 50 percent deaths were among women. Along with these, growing occurrence of infectious disorders such as hepatitis and HIV in women all around the world is also expected to boost the growth of the market significantly in the forthcoming years. Furthermore, since the past few years, immunoassays, a highly popular platforms for diagnosing several conditions among women, are receiving surge in the number of regulatory approvals from medical bodies worldwide. This in turn is projected to offer ample growth opportunities to the market in the near future.
Women Health Diagnostics Sector: Growth Drivers and Challenges
Growth Drivers
- Rising Awareness Levels About Various Health Disorders Globally
- Increasing Prevalence of Lifestyle and Chronic Diseases Among Women
Challenges
- High Cost of Diagnostic Imaging Procedures and Systems
Women Health Diagnostics Market: Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
7.2% |
|
Base Year Market Size (2024) |
USD 19.97 billion |
|
Forecast Year Market Size (2037) |
USD 49.31 billion |
|
Regional Scope |
|
Women Health Diagnostics Segmentation
The women health diagnostics market is segmented by application into breast cancer, infectious disease testing, osteoporosis testing, pregnancy & fertility testing, sexually transmitted disease testing, and others. Out of these, the breast cancer segment is anticipated to hold the largest share in the global women’s health diagnostics market. This can be accounted to the increasing burden of breast cancer globally, and rise in investments in research and development for cancer diagnosis. Apart from these, provision of reimbursement and insurance coverage for breast cancer diagnosis in developed nations is also assessed to drive growth to the market segment in the future. Additionally, on the basis of end user, the home care segment is assessed to observe robust growth during the forecast period owing to the growing preference for using self-testing kits amongst women for various conditions, such as ovulation and pregnancy, as a result of their convenience of diagnosis.
Our in-depth analysis of the global market includes the following segments
|
By Application |
|
|
By End User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Women Health Diagnostics Industry - Regional Synopsis
APAC Market Statistics
Regionally, the global women health diagnostics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. Asia Pacific industry is poised to dominate majority revenue share by 2037, impelled by large patient pool, and surging improvements in the healthcare infrastructure.
North America Market Analysis
Moreover, the women health diagnostics market in North America is expected to grab the largest share during the forecast period, which can be credited primarily to the growing occurrence of cancer among women in the region. As per the National Cancer Institute, the rate of new cases of female breast cancer in the United States was 129.1 per 100,000 women per year. The rate is age-adjusted and based on 2014–2018 cases and 2015–2019 deaths. In addition, increasing demand for fertility test monitors, and high emphasis of pharmaceutical manufacturers on expanding their presence are also predicted to bolster the growth of the market in the region in the coming years.
Companies Dominating the Women Health Diagnostics Landscape
- Siemens AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- F. Hoffmann-La Roche Ltd.
- Cardinal Health, Inc.
- General Electric Company
- Hologic, Inc.
- Becton, Dickinson and Company
- Quest Diagnostics, Inc.
- PerkinElmer Inc.
- Alere Inc.
- Biomérieux SA
Recent Developments
-
August 2021- Siemens Healthineers and TeamViewer announced a partnership for enabling new digital models to combat the shortage of skilled radiology technologists in healthcare facilities.
-
September 2020- GE Healthcare unveiled Voluson SWIFT, an AI-enhanced women’s health ultrasound system with industry first auto recognition tools to improve efficiency.
- Report ID: 3844
- Published Date: Dec 26, 2024
- Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Women Health Diagnostics Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
